Inventor
POWERS JAY
US31 patents
⚠️ This page may combine multiple inventors who share the name “POWERS JAY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHEMOCENTRYX INC
19 patentsUS10035768B2Jul 31, 2018
C5aR antagonists
CHEMOCENTRYX INC23 citations94
US9573897B2Feb 21, 2017
C5AR antagonists
CHEMOCENTRYX INC24 citations94
US7776877B2Aug 17, 2010
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
CHEMOCENTRYX INC11 citations92
US9745268B2Aug 29, 2017
Processes and intermediates in the preparation of C5aR antagonists
CHEMOCENTRYX INC11 citations91
US11142521B2Oct 12, 2021
Substituted anilines as CCR(4) antagonists
CHEMOCENTRYX INC4 citations84
US10660897B2May 26, 2020
C5aR antagonists
CHEMOCENTRYX INC6 citations84
US10532982B2Jan 14, 2020
Processes and intermediates in the preparation of C5aR antagonists
CHEMOCENTRYX INC4 citations84
US10266492B2Apr 23, 2019
Processes and intermediates in the preparation of C5aR antagonists
CHEMOCENTRYX INC8 citations84
US9758512B2Sep 12, 2017
Substituted anilines as CCR(4) antagonists
CHEMOCENTRYX INC6 citations84
US9567323B2Feb 14, 2017
Substituted anilines as CCR(4) antagonists
CHEMOCENTRYX INC6 citations84
US8835419B2Sep 16, 2014
Substituted anilines as CCR(4) antagonists
CHEMOCENTRYX INC9 citations83
US10407417B2Sep 10, 2019
Substituted anilines as CCR(4) antagonists
CHEMOCENTRYX INC3 citations73
US9790204B2Oct 17, 2017
Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
CHEMOCENTRYX INC2 citations73
US9150550B2Oct 6, 2015
Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
CHEMOCENTRYX INC2 citations63
US8685959B2Apr 1, 2014
Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
CHEMOCENTRYX INC2 citations63
US11884654B2Jan 30, 2024
Substituted anilines as CCR(4) antagonists
CHEMOCENTRYX INC0 citations62
US11845729B2Dec 19, 2023
Processes and intermediates in the preparation of C5aR antagonists
CHEMOCENTRYX INC0 citations62
US9409909B2Aug 9, 2016
N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides
CHEMOCENTRYX INC2 citations62
US10647696B2May 12, 2020
Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists
CHEMOCENTRYX INC0 citations52
ARCUS BIOSCIENCES INC
3 patentsUS10399962B2Sep 3, 2019
Azolopyrimidine for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC13 citations80
US11072597B2Jul 27, 2021
Azolopyrimidine for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC3 citations69
US12195447B2Jan 14, 2025
Azolopyrimidine for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC1 citations60